Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry.
Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J, Henderson W, Grover F, Ramanathan KB, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Murphy E, Ward H, Miller L, Kiesz S, Barbiere C, Lewis D; Investigators of the Dept. of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Sedlis SP, et al. Among authors: ramanathan kb. J Am Coll Cardiol. 2002 Nov 6;40(9):1555-66. doi: 10.1016/s0735-1097(02)02346-x. J Am Coll Cardiol. 2002. PMID: 12427406 Free article. Clinical Trial.
Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry).
Sedlis SP, Ramanathan KB, Morrison DA, Sethi G, Sacks J, Henderson W; Department of Veterans Affairs Cooperative Study #385, Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) Investigators. Sedlis SP, et al. Among authors: ramanathan kb. Am J Cardiol. 2004 Jul 1;94(1):118-20. doi: 10.1016/j.amjcard.2004.03.041. Am J Cardiol. 2004. PMID: 15219521 Clinical Trial.
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME).
Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan K, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D; Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Morrison DA, et al. J Am Coll Cardiol. 2001 Jul;38(1):143-9. doi: 10.1016/s0735-1097(01)01366-3. J Am Coll Cardiol. 2001. PMID: 11451264 Free article. Clinical Trial.
A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs.
Morrison DA, Sethi G, Sacks J, Grover F, Sedlis S, Esposito R, Ramanathan KB, Weiman D, Krucoff M, Duhaylongsod F, Raya T, Pett S, Vernon S, Birjiniuk V, Booth D, Robinson C, Talley JD, Antckli T, Murphy E, Floten H, Curcovic V, Lucke JC, Lewis D, Barbiere C, Henderson W. Morrison DA, et al. Among authors: ramanathan kb. Control Clin Trials. 1999 Dec;20(6):601-19. doi: 10.1016/s0197-2456(99)00033-1. Control Clin Trials. 1999. PMID: 10588300 Clinical Trial.
Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study).
Saucedo JF, Garza L, Wolford DC, Cook SL, Ramanathan KB, Matin Z, McGrew FA, Jacoski MV, Jennings LK; Tennessee-Arkansas-Mississippi (TAM) Clinical Research Consortium. Saucedo JF, et al. Among authors: ramanathan kb. Am J Cardiol. 2004 May 15;93(10):1279-82. doi: 10.1016/j.amjcard.2004.02.014. Am J Cardiol. 2004. PMID: 15135704 Clinical Trial.
Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.
Bittner V, Bertolet M, Barraza Felix R, Farkouh ME, Goldberg S, Ramanathan KB, Redmon JB, Sperling L, Rutter MK; BARI 2D Study Group. Bittner V, et al. Among authors: ramanathan kb. J Am Coll Cardiol. 2015 Aug 18;66(7):765-773. doi: 10.1016/j.jacc.2015.06.019. J Am Coll Cardiol. 2015. PMID: 26271057 Free PMC article. Clinical Trial.
108 results